Cargando…
Cell Immunotherapy against Melanoma: Clinical Trials Review
Melanoma is one of the most aggressive and therapy-resistant types of cancer, the incidence rate of which grows every year. However, conventional methods of chemo- and radiotherapy do not allow for completely removing neoplasm, resulting in local, regional, and distant relapses. In this case, adjuva...
Autores principales: | Filin, Ivan Y., Mayasin, Yuri P., Kharisova, Chulpan B., Gorodilova, Anna V., Kitaeva, Kristina V., Chulpanova, Daria S., Solovyeva, Valeriya V., Rizvanov, Albert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916554/ https://www.ncbi.nlm.nih.gov/pubmed/36768737 http://dx.doi.org/10.3390/ijms24032413 |
Ejemplares similares
-
T-Lymphocytes Activated by Dendritic Cells Loaded by Tumor-Derived Vesicles Decrease Viability of Melanoma Cells In Vitro
por: Filin, Ivan Yurevich, et al.
Publicado: (2023) -
The Potential of Dendritic Cell Subsets in the Development of Personalized Immunotherapy for Cancer Treatment
por: Gorodilova, Anna Valerevna, et al.
Publicado: (2023) -
Analysis of the Interaction of Human Neuroblastoma Cell-Derived Cytochalasin B Induced Membrane Vesicles with Mesenchymal Stem Cells Using Imaging Flow Cytometry
por: Solovyeva, Valeriya V., et al.
Publicado: (2022) -
Mouse Tumor Models for Advanced Cancer Immunotherapy
por: Chulpanova, Daria S., et al.
Publicado: (2020) -
Current Trends in Cancer Immunotherapy
por: Filin, Ivan Y., et al.
Publicado: (2020)